Press release
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa
Hyperopia Market
Emerging therapies for Hyperopia, including NVK-033 and others, are anticipated to drive growth in the Hyperopia market over the coming years.
DelveInsight has released a new report titled "Hyperopia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/hyperopia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]", offering comprehensive insights into Hyperopia, along with historical and projected epidemiology and market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Explore more about Hyperopia market report 2034 @ https://www.delveinsight.com/report-store/hyperopia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Some of the key facts of the Hyperopia Market Report:
*
In 2023, the total Hyperopia market size across the 7MM was estimated at around USD 3.2 billion, with the current treatment landscape largely dominated by corrective lenses and surgical procedures.
*
The market remains relatively underdeveloped, as no pharmacological therapies have yet been approved. However, Vyluma's NVK-033, currently in the clinical proof-of-principle stage, holds promise as a potential first-in-class drug for Hyperopia.
*
In the United States, the highest prevalence of Hyperopia was noted in individuals aged 60-69 years, accounting for nearly 25% of reported cases.
*
In January 2025, ZEISS Medical Technology received FDA approval for the MEL Registered 90 excimer laser to treat myopia, hyperopia, and mixed astigmatism. Designed to integrate with the Corneal Refractive Workflow, the MEL 90 provides surgeons with a fast, efficient, and reliable surgical solution, complementing the VISUMAX Registered 800 with SMILE Registered pro to further advance refractive care and improve patient outcomes.
*
Key Hyperopia players such as Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Companies Inc., Johnson & Johnson Vision, NIDEK CO. LTD, Topcon Corporation, Essilor Luxottica (Essilor Ltd), Regeneron Pharmaceuticals Inc., Orasis Pharmaceuticals, The Cooper Companies Inc., and others are actively evaluating new therapies to transform the treatment landscape.
*
Promising pipeline therapies include NVK-033 and additional candidates in development.
Key benefits of the Hyperopia market report:
*
Hyperopia market report covers a descriptive overview and comprehensive insight of the Hyperopia Epidemiology and Hyperopia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
*
The Hyperopia market report provides insights on the current and emerging therapies.
*
Hyperopia market report provides a global historical and forecasted market covering drug outreach in 7MM.
*
The Hyperopia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Hyperopia market.
Got queries? Click here to know more about the Hyperopia Market Landscape @ https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Hyperopia Overview
Hyperopia, commonly known as farsightedness, is a refractive error of the eye in which distant objects are seen more clearly than near ones. It occurs when light entering the eye focuses behind the retina instead of directly on it, usually due to a shorter-than-normal eyeball or an abnormally flat cornea.
Hyperopia Market Outlook
Hyperopia, also known as farsightedness, is a refractive condition in which distant vision is clearer than near vision. It can occur across all age groups and often impacts daily tasks such as reading or digital device use. The increasing prevalence of hyperopia continues to fuel market growth. Treatment needs vary with severity-mild to moderate cases are usually corrected with eyeglasses or contact lenses. In 2018, the US FDA approved Acuvue Oasys Contact Lenses, the first lenses designed to automatically darken under bright light. For patients who do not achieve sufficient improvement with lenses, surgical interventions such as LASIK or Refractive Lens Exchange (RLE) are available to enhance focusing ability. Additional procedures, including LASEK, PRK, and Conductive Keratoplasty, offer alternatives but require detailed counseling to weigh their risks and benefits.
Discover how the Hyperopia market is growing in the coming years @ https://www.delveinsight.com/report-store/hyperopia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Hyperopia Emerging Therapy Assessment
*
NVK-033: Vyluma
Scope of the Hyperopia Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Hyperopia Companies: Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Companies Inc., Johnson & Johnson Vision, NIDEK CO. LTD, Topcon Corporation, Essilor Luxottica (Essilor Ltd), Regeneron Pharmaceuticals Inc., Orasis Pharmaceuticals, The Cooper Companies Inc., and others
*
Key Hyperopia Therapies: NVK-033, and others
*
Hyperopia Therapeutic Assessment: Hyperopia current marketed and Hyperopia emerging therapies
*
Hyperopia Market Dynamics: Hyperopia market drivers and Hyperopia market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Hyperopia Unmet Needs, KOL's views, Analyst's views, Hyperopia Market Access and Reimbursement
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Hyperopia Patient Share (%) Overview at a Glance
5. Hyperopia Market Overview at a Glance
6. Hyperopia Disease Background and Overview
7. Hyperopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Hyperopia
9. Hyperopia Current Treatment and Medical Practices
10. Unmet Needs
11. Hyperopia Emerging Therapies
12. Hyperopia Market Outlook
13. Country-Wise Hyperopia Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Hyperopia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Hyperopia Market Outlook 2034 [https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Related Reports:
Hyperopia Pipeline Insights, DelveInsight
"Hyperopia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Hyperopia market. A detailed picture of the Hyperopia pipeline landscape is provided, which includes the disease overview and Hyperopia treatment guidelines.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hyperopia-market-overview-epidemiology-emerging-therapies-and-key-players-featuring-nevakar-zeimer-ophthalmic-systems-ag-carl-zeiss-meditec-ag-abbvie-sydnexis-alcon-inc-bausch-health-compa]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa here
News-ID: 4178155 • Views: …
More Releases from ABNewswire
Central serous chorioretinopathy Pipeline Analysis & Clinical Trials, 2025, Delv …
DelveInsight's, "Central Serous Chorioretinopathy - Pipeline Insight, 2025," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Central Serous Chorioretinopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that the Central Serous Chorioretinopathy (CSC)…
Meibomian gland dysfunction Pipeline Analysis & Clinical Trials, 2025, DelveInsi …
"DelveInsight's, "Meibomian Gland Dysfunction- Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Meibomian Gland Dysfunction pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Meibomian Gland Dysfunction pipeline includes…
Centronuclear Myopathy Pipeline 2025: Pioneering Clinical Developments Led by 5+ …
DelveInsight's, "Obesity - Pipeline Insight, 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Obesity pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
The Centronuclear Myopathy market is largely driven by the significant unmet medical…
September Savings With Mill Ends: How to Save Up to 50% on Carpet at Warehouse D …
Santa Cruz Family Business Offers Unbeatable Deals on Name-Brand Carpets from Shaw, Mohawk, and Other Top Manufacturers. Warehouse Direct Flooring Outlet is announcing its September mill ends carpet sale featuring mill end carpets at up to 50% off their MSRP prices. The locally-owned flooring specialist is offering significant savings on name-brand carpets while supplies last, with the most popular and highest-value carpeting expected to sell out quickly.
Image: https://www.abnewswire.com/upload/2025/09/9d2f7f6f299145520c3a8bb79af7b652.jpg
Most property owners…
More Releases for Hyperopia
Global Hyperopia Treatment Market to Expand at 7.5% of CAGR Through 2025-2033, S …
Overview of the Market:
The Global Hyperopia Treatment Market has gained strong momentum in recent years, driven by rising cases of refractive errors, advancements in laser eye surgery, and growing awareness about early eye care. Hyperopia, commonly known as farsightedness, is a vision condition in which distant objects can be seen clearly, but nearby objects appear blurry. The increasing prevalence of hyperopia across both developed and emerging economies is creating significant…
Hyperopia Treatment Market Growth, Trends & Opportunities 2025-2033 | Top key pl …
Hyperopia Treatment Market, as analyzed in the study by DataM Intelligence, presents a detailed overview of the industry with in-depth insights, historical data, and key statistics. The report thoroughly examines market dynamics, competitive strategies, and major players, highlighting their product lines, pricing structures, financials, growth plans, and regional outreach.
The Global Hyperopia Treatment Market reached US$ 3,427.36 million in 2024 and is expected to reach US$ 6,651.86 million by 2033, growing…
Hyperopia Treatment Market: Innovative Solutions, Trends, and Growth Opportuniti …
The Global Hyperopia Treatment Market reached US$ 3,427.36 million in 2024 and is expected to reach US$ 6,651.86 million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Hyperopia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…
Hyperopia Market on Track for Major Expansion by 2034, According to DelveInsight …
The Key Hyperopia Companies in the market include - Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others.
DelveInsight's "Hyperopia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hyperopia, historical and forecasted epidemiology as well as the Hyperopia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hyperopia market outlook,…
Hyperopia Market to Witness Upsurge in Growth During the Forecast Period (2024-2 …
DelveInsight's "Hyperopia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Hyperopia, historical and forecasted epidemiology as well as the Hyperopia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hyperopia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hyperopia Market Forecast
https://www.delveinsight.com/sample-request/hyperopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Hyperopia…
Hyperopia Glasses Market - Latest Scenario on Innovation, Revolutionary Opportun …
The hyperopia glasses market is driven by factors such as the growing prevalence of hyperopia, the desire for corrective eyewear that combines functionality with fashion, and advancements in lens materials and coatings. As vision correction remains a priority for many individuals, the market is expected to continue evolving with innovations in eyewear technology and consumer preferences. Hyperopia, commonly known as farsightedness, is a vision condition where distant objects are seen…
